Safety of joint puncture in patients receiving anticoagulant therapy with dabigatran.

3. Jandali B, Uthman I, Abbas O. Interstitial granulomatous dermatitis associated with systemic lupus erythematosus: case report and review of the literature. Lupus. 2016;25:209–13. 4. Krauter A, Gambichler T, Altmeyer P. Infliximab therapy for interstitial granulomatous dermatitis. J Eur Acad Dermatol Venereol. 2007;21:251–2. 5. Ahmed ZS, Joad S, Singh M, Bandagi SS. Interstitial granulomatous dermatitis successfully treated with etanercept. Am J Case Rep. 2014;15:94–6. 6. Schanz S, Schmatzung M, Guenova E, Metzler G, Ulmar A, Kötter I, et al. Interstitial granulomatous dermatitis with arthritis responding to tocilizumab. Arch Dermatol. 2012;148:17–22150. 7. Leloup P, Aubert H, Causse S, LeGoff B, Barbarot S. Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis. JAMA Dermatol. 2013;149:626–7. 8. Alghamdi R, Bejar C, Steff M, Deschamps L, Marinho E, Crickx B, et al. Intravenous immunoglobulins as a treatment of interstitial granulomatous dermatitis with arthritis. Br J Dermatol. 2012;167V:218–20. 9. Collins CE, Dall’Era M, Kan H, Macahilig C, Molta C, Koscielny V, et al. Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA. Lupus Sci Med. 2016;3:e000118. 10. Verneuil L, Dompmartin A, Comoz F, Pasquier CJ, Leroy D. Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies. J Am Acad Dermatol. 2001;45:286–91.